AU476619B2 - Method of detecting antigens or antibodies - Google Patents

Method of detecting antigens or antibodies

Info

Publication number
AU476619B2
AU476619B2 AU73787/74A AU7378774A AU476619B2 AU 476619 B2 AU476619 B2 AU 476619B2 AU 73787/74 A AU73787/74 A AU 73787/74A AU 7378774 A AU7378774 A AU 7378774A AU 476619 B2 AU476619 B2 AU 476619B2
Authority
AU
Australia
Prior art keywords
antibodies
detecting antigens
antigens
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU73787/74A
Other languages
English (en)
Other versions
AU7378774A (en
Inventor
Bornstein Andreas A. Kapsalis Irene
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of AU7378774A publication Critical patent/AU7378774A/en
Application granted granted Critical
Publication of AU476619B2 publication Critical patent/AU476619B2/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
AU73787/74A 1973-10-26 1974-09-30 Method of detecting antigens or antibodies Expired AU476619B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USUS410066 1973-10-26
US05/410,066 US3949064A (en) 1973-10-26 1973-10-26 Method of detecting antigens or antibodies

Publications (2)

Publication Number Publication Date
AU7378774A AU7378774A (en) 1976-04-01
AU476619B2 true AU476619B2 (en) 1976-09-30

Family

ID=23623067

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73787/74A Expired AU476619B2 (en) 1973-10-26 1974-09-30 Method of detecting antigens or antibodies

Country Status (15)

Country Link
US (2) US3949064A (OSRAM)
JP (1) JPS5762020B2 (OSRAM)
AU (1) AU476619B2 (OSRAM)
BE (1) BE820660A (OSRAM)
BR (1) BR7408886A (OSRAM)
CA (1) CA1036493A (OSRAM)
DE (1) DE2450523C3 (OSRAM)
ES (1) ES431413A1 (OSRAM)
FR (1) FR2249334B1 (OSRAM)
GB (1) GB1436934A (OSRAM)
IL (1) IL45707A (OSRAM)
LU (1) LU71027A1 (OSRAM)
NL (1) NL7413552A (OSRAM)
SE (1) SE7413484L (OSRAM)
ZA (1) ZA746098B (OSRAM)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172117A (en) * 1974-05-20 1979-10-23 Biotest-Serum-Institut Gmbh Method for the simultaneous measurement of antigens and their antibodies by solid-phase radioimmunoassay
US4225784A (en) * 1976-06-17 1980-09-30 Smith Kline Instruments, Inc. Covalently bound biological substances to plastic materials and use in radioassay
AT343822B (de) * 1976-08-20 1978-06-26 Immuno Ag Radioimmunologisches verfahren und einrichtung zur bestimmung von antigenen
JPS604422B2 (ja) * 1976-10-07 1985-02-04 持田製薬株式会社 抗原の定量方法
USRE34394E (en) * 1978-01-23 1993-09-28 Baxter Diagnostics Inc. Method and composition for double receptor, specific binding assays
JPS608745B2 (ja) * 1978-02-14 1985-03-05 三洋化成工業株式会社 免疫活性物質−つや消しガラス複合体，その製造法及び該複合体を含有してなる測定試薬
US4242322A (en) * 1978-06-07 1980-12-30 Electro-Nucleonics Laboratories, Inc. Methods and materials for detecting antigens and antibodies
US4393040A (en) * 1981-03-24 1983-07-12 Lopapa Institute, Inc. In-vitro diagnostic method for detection of acetylsalicylic acid ingestion
US4994373A (en) 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
PH21409A (en) * 1983-07-21 1987-10-15 Scripps Clinic Res Synthetic polypeptides and pharmaceutical composition containing the same
US5242798A (en) * 1983-07-21 1993-09-07 Scripps Clinic And Research Foundation Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
CA1255586A (en) * 1984-07-24 1989-06-13 Hendrik M. Geysen Method of determining mimotopes
US5182082A (en) * 1991-01-23 1993-01-26 Becton, Dickinson And Company Multiple aliquot device for distributing a liquid solution into a well
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US5877028A (en) * 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US5998220A (en) * 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
US5698686A (en) * 1994-10-20 1997-12-16 Arch Development Corporation Yeast telomerase compositions
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
AU727445B2 (en) * 1995-08-18 2000-12-14 Donald W Landry Detection of organic compounds through regulation of antibody-catalyzed reactions
US6689757B1 (en) 1996-02-12 2004-02-10 M.L. Laboratories Plc Methods for vaccination and vaccines therefor
US20020034732A1 (en) * 1997-07-30 2002-03-21 Daniel J. Capon Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6610838B1 (en) 1997-09-10 2003-08-26 Symbicom Aktiebolag P13 antigens from Borrelia
HK1044040A1 (zh) * 1998-11-16 2002-10-04 德克萨斯州立大学董事会 Hiv-特异的t-细胞诱导
US7060462B2 (en) * 2000-11-02 2006-06-13 National University Of Singapore AopB gene, protein,homologs, fragments and variants thereof, and their use for cell surface display
EP1572714A4 (en) 2002-12-20 2006-08-09 Univ Texas VMP-Similar Sequences of Pathogenic Borrelia Species and Stem
WO2005035556A2 (en) * 2003-05-06 2005-04-21 Iguazu Biosciences Corp. Sars-coronavirus virus-like particles and methods of use
CA2526690C (en) 2003-05-23 2014-01-14 Board Of Regents The University Of Texas System Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
EP2368570A3 (en) 2006-01-18 2012-05-02 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
WO2008097817A2 (en) * 2007-02-02 2008-08-14 Baylor Research Institute Multivariable antigens complexed with targeting humanized monoclonal antibody
CN101679508B (zh) 2007-02-02 2014-11-05 贝勒研究院 基于靶向抗原至抗原呈递细胞上表达的dcir的疫苗
TWI422594B (zh) 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
BRPI0807613A2 (pt) * 2007-02-23 2014-06-10 Baylor Res Inst Ativação de antígeno humano presente em células através de clec-6
AU2008218190C1 (en) * 2007-02-23 2013-05-02 Baylor Research Institute Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)
CA2717659C (en) * 2007-02-23 2017-08-22 Baylor Research Institute Therapeutic applications of activation of human antigen-presenting cells through dectin-1
US9138470B2 (en) * 2007-11-02 2015-09-22 The Johns Hopkins University Multi-component L2 vaccine for prevention of human papilloma virus infection
EP2966091B1 (en) * 2008-07-16 2018-04-25 Baylor Research Institute Agonistic anti-cd40 antibodies
EP2341929B1 (en) 2008-10-06 2017-01-25 University Of Chicago Compositions and methods related to bacterial emp proteins
HUE026855T2 (en) 2009-04-03 2016-07-28 Univ Chicago Compositions and methods related to protein a (spa) variants
US10080799B2 (en) 2010-02-12 2018-09-25 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions related to glycoprotein-immunoglobulin fusions
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
SG186290A1 (en) 2010-07-02 2013-01-30 Univ Chicago Compositions and methods related to protein a (spa) variants
US9095540B2 (en) 2010-09-09 2015-08-04 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
EP2633062B1 (en) 2010-10-29 2017-12-27 Life Technologies Corporation Biotin derivatives
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
PL2844275T3 (pl) 2012-04-26 2021-03-08 University Of Chicago Koagulazy gronkowcowe stanowiące antygeny i sposoby ich zastosowania
WO2014052588A1 (en) 2012-09-27 2014-04-03 Research Development Foundation Attenuated chikungunya virus
EP2964254B1 (en) 2013-03-07 2019-09-18 University of Maryland, Baltimore Immunotherapeutic potential of modified lipooligosaccharides/lipid a
IL300029A (en) 2014-05-16 2023-03-01 Baylor Res Institute Methods and preparations for the treatment of autoimmune and inflammatory conditions
US10662226B2 (en) 2016-10-28 2020-05-26 The Regents of the University of Caiifomia Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
WO2019183500A1 (en) 2018-03-23 2019-09-26 Hung Chiung Yu Coccidioides antigens and methods of their use
WO2020041360A1 (en) 2018-08-21 2020-02-27 Quidel Corporation Dbpa antibodies and uses thereof
WO2020193718A1 (en) 2019-03-27 2020-10-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Recombinant proteins with cd40 activating properties
US12514914B2 (en) 2019-05-14 2026-01-06 The University Of Chicago Methods and compositions comprising Staphylococcus protein a (SpA) variants
WO2021099576A1 (en) 2019-11-21 2021-05-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel immunotherapies targeting pd-1 with anti-pd-1/il-15 immunocytokines
US11376320B2 (en) 2020-03-05 2022-07-05 Iowa State University Research Foundation, Inc. Immunogenic and vaccine compositions against SARS-CoV-2
EP4149974A1 (en) 2020-05-13 2023-03-22 Institut National de la Santé et de la Recherche Médicale (INSERM) Recombinant proteins with ox40 activating properties
EP4469079A1 (en) 2022-01-28 2024-12-04 Pfizer Inc. Coronavirus antigen variants
WO2025017036A1 (en) 2023-07-17 2025-01-23 Institut National de la Santé et de la Recherche Médicale Alphavirus nsp3 helical tubular scaffolds
WO2025027492A1 (en) 2023-07-31 2025-02-06 Pfizer Inc. Coronavirus antigen variants
WO2025257397A1 (en) 2024-06-14 2025-12-18 Institut National de la Santé et de la Recherche Médicale Live attenuated bordetella vaccines capable of producing and secreting heterologous antigens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (OSRAM) * 1967-05-23 1971-08-02 Pharmacia Ab
SE343210B (OSRAM) * 1967-12-20 1972-03-06 Pharmacia Ab
US3646346A (en) * 1968-12-26 1972-02-29 Pharmacia Ab Antibody-coated tube system for radioimmunoassay
US3867517A (en) * 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies

Also Published As

Publication number Publication date
DE2450523B2 (de) 1976-10-07
SE7413484L (OSRAM) 1975-04-28
BR7408886A (pt) 1976-05-04
ZA746098B (en) 1975-11-26
JPS5762020B2 (OSRAM) 1982-12-27
GB1436934A (en) 1976-05-26
NL7413552A (nl) 1975-04-29
ES431413A1 (es) 1976-10-16
AU7378774A (en) 1976-04-01
USRE29955E (en) 1979-04-03
FR2249334B1 (OSRAM) 1977-03-25
CA1036493A (en) 1978-08-15
IL45707A (en) 1977-01-31
LU71027A1 (OSRAM) 1975-04-17
US3949064A (en) 1976-04-06
IL45707A0 (en) 1974-11-29
JPS5075095A (OSRAM) 1975-06-20
BE820660A (fr) 1975-02-03
FR2249334A1 (OSRAM) 1975-05-23
DE2450523C3 (de) 1978-06-22
DE2450523A1 (de) 1975-05-22

Similar Documents

Publication Publication Date Title
AU476619B2 (en) Method of detecting antigens or antibodies
CA1034042A (en) Process for qualitative analysis or quantitation of antigens or antibodies
CA988420A (en) Direct radioimmunoassay for antigens and their antibodies
CA1023287A (en) Process for the preparation of carrier-bound proteins
ZA743465B (en) Method for determination of the presence of antibiotics
CA1024426A (en) Method for the determination of amylase
CA1004344A (en) Seismic velocity determination
IL47664A (en) Radioimmune assay method for detection of gonorrhoeae antibodies
CA1003733A (en) Radioactive determination of serum thyroxine
AU505801B2 (en) Detecting antibodies
CA1012661A (en) Method for the analysis of isotopes
CA1018236A (en) Electrophotographic method
CA960207A (en) Method for detecting geopressures
AU5891173A (en) METHOD FOR SEPARATION OF 5-ISOPROPYL-m-CRESOL
ATA402674A (de) Verfahren zur herstellung von flaschenkapseln
AU474605B2 (en) METHOD FOR SEPARATION OF 5-ISOPROPYL-m-CRESOL
CA834128A (en) Method of preparing antibodies
CA927526A (en) Method of prospecting
CA1033294A (en) Contrast enhancement for immunological film detection
AU489779B2 (en) Radioimmune assay method for detection of gonorrhea antibodies
AU496869B2 (en) Method for determination ofthe presence of antibiotics
BG26200A3 (bg) Метод за получаване на 7-алфа-(3-гуанил-1-уреидо)- фенилацетамидо-3-субституирани цефалоспорини
AU447400B2 (en) Method of detecting subsurface objects
AU481845B2 (en) Process for qualitative analysis or quantitation of antigens or antibodies
CA907479A (en) Reagent for determination of globulin